Insider Selling: CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) Major Shareholder Sells 532,486 Shares of Stock

CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) major shareholder Stuart M. Sloan sold 532,486 shares of CERo Therapeutics stock in a transaction on Wednesday, September 25th. The stock was sold at an average price of $0.10, for a total value of $53,248.60. Following the completion of the sale, the insider now directly owns 21,067,956 shares of the company’s stock, valued at approximately $2,106,795.60. The trade was a 2.47 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link. Large shareholders that own 10% or more of a company’s shares are required to disclose their transactions with the SEC.

CERo Therapeutics Stock Performance

Shares of CERO stock traded down $0.01 on Wednesday, reaching $0.25. The stock had a trading volume of 13,365,594 shares, compared to its average volume of 20,742,855. CERo Therapeutics Holdings, Inc. has a 1 year low of $0.06 and a 1 year high of $12.80. The company has a 50 day simple moving average of $0.11 and a 200 day simple moving average of $0.33.

CERo Therapeutics Company Profile

CERo Therapeutics Holdings, Inc, an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.